Viridian Therapeutics Stock Forecast - Naive Prediction
| 0K1R Stock | 15.90 0.56 3.40% |
The Naive Prediction forecasted value of Viridian Therapeutics on the next trading day is expected to be 17.82 with a mean absolute deviation of 0.61 and the sum of the absolute errors of 37.67. Viridian Stock Forecast is based on your current time horizon.
Viridian |
Viridian Therapeutics Naive Prediction Price Forecast For the 16th of March 2025
Given 90 days horizon, the Naive Prediction forecasted value of Viridian Therapeutics on the next trading day is expected to be 17.82 with a mean absolute deviation of 0.61, mean absolute percentage error of 0.62, and the sum of the absolute errors of 37.67.Please note that although there have been many attempts to predict Viridian Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Viridian Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Viridian Therapeutics Stock Forecast Pattern
| Backtest Viridian Therapeutics | Viridian Therapeutics Price Prediction | Buy or Sell Advice |
Viridian Therapeutics Forecasted Value
In the context of forecasting Viridian Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Viridian Therapeutics' downside and upside margins for the forecasting period are 14.13 and 21.52, respectively. We have considered Viridian Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Viridian Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Viridian Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 119.465 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.6075 |
| MAPE | Mean absolute percentage error | 0.0338 |
| SAE | Sum of the absolute errors | 37.6666 |
Predictive Modules for Viridian Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Viridian Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Viridian Therapeutics
For every potential investor in Viridian, whether a beginner or expert, Viridian Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Viridian Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Viridian. Basic forecasting techniques help filter out the noise by identifying Viridian Therapeutics' price trends.Viridian Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Viridian Therapeutics stock to make a market-neutral strategy. Peer analysis of Viridian Therapeutics could also be used in its relative valuation, which is a method of valuing Viridian Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Viridian Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Viridian Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Viridian Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Viridian Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Viridian Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Viridian Therapeutics shares will generate the highest return on investment. By undertsting and applying Viridian Therapeutics stock market strength indicators, traders can identify Viridian Therapeutics entry and exit signals to maximize returns.
Viridian Therapeutics Risk Indicators
The analysis of Viridian Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Viridian Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting viridian stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.24 | |||
| Standard Deviation | 5.23 | |||
| Variance | 27.33 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Viridian Stock Analysis
When running Viridian Therapeutics' price analysis, check to measure Viridian Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viridian Therapeutics is operating at the current time. Most of Viridian Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viridian Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viridian Therapeutics' price. Additionally, you may evaluate how the addition of Viridian Therapeutics to your portfolios can decrease your overall portfolio volatility.